| Application no. and date | 20708283.5 (espacenet) (Federated) (European Patent Register), 20200122 | | Patent/reg. no. and date | DK/EP 3914247, 20241113 | | Publication date | 20211201 | | Priority no. and date | US 201962795524 P, 20190122 | | EP pub. no. and date |
EP 3914247 20211201 | | Effective date | | | Applicant/owner | Amicus Therapeutics, Inc., 3675 Market Street
Philadelphia, PA 19104, US | | Applicant ref. no. | 1729632 | | Inventor | SKUBAN, Nina, Amicus Therapeutics, Inc. 1 Cedar Brook Drive
Cranbury, New Jersey 08512, US,
LAGAST, Hjalmar, Amicus Therapeutics, Inc. 1 Cedar Brook Drive
Cranbury, New Jersey 08512, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/445 (2006.01) , A61P 25/00 (2006.01) , A61P 9/00 (2006.01) | | Title | ANVENDELSE AF MIGALOSTAT TIL REDUCERING AF RISIKOEN FOR CEREBROVASKULÆR HÆNDELSE HOS PATIENTER MED FABRYS SYGDOM | | Int. application no. | US2020014531 | | Int. publication no. | WO2020154354 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
